These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2031839)

  • 1. Low-dose and heparin-free hemodialysis in children.
    Geary DF; Gajaria M; Fryer-Keene S; Willumsen J
    Pediatr Nephrol; 1991 Mar; 5(2):220-4. PubMed ID: 2031839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
    Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
    Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center.
    Lord H; Jean N; Dumont M; Kassis J; Leblanc M
    Am J Nephrol; 2002; 22(1):58-66. PubMed ID: 11919404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodialysis using heparin-bound Hemophan in patients at risk of bleeding.
    Lee KB; Kim B; Lee YH; Yoon SJ; Kang WH; Huh W; Kim DJ; Oh HY; Kim YG
    Nephron Clin Pract; 2004; 97(1):c5-10. PubMed ID: 15153761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.
    Islam MS; Hassan ZA; Chalmin F; Vido S; Berrada M; Verhelst D; Donnadieu P; Moranne O; Esnault VL
    Am J Kidney Dis; 2016 Nov; 68(5):752-762. PubMed ID: 27344212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin free dialysis: comparative data and results in high risk patients.
    Caruana RJ; Raja RM; Bush JV; Kramer MS; Goldstein SJ
    Kidney Int; 1987 Jun; 31(6):1351-5. PubMed ID: 3613407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vitamin-E-modified dialysers on dialyser clotting, erythropoietin and heparin dosage: a comparative crossover study.
    Huraib S; Tanimu D; Shaheen F; Hejaili F; Giles C; Pagayon V
    Am J Nephrol; 2000; 20(5):364-8. PubMed ID: 11092992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-free hemodialysis with an oral anti-platelet agent.
    Teraoka S; Naganuma S; Takahashi K; Ota K
    ASAIO J; 1992; 38(3):M560-3. PubMed ID: 1457921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precise anticoagulation for routine hemodialysis.
    Farrell PC; Ward RA; Schindhelm K; Gotch F
    J Lab Clin Med; 1978 Aug; 92(2):164-76. PubMed ID: 681809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-free hemodialysis with prophylactic change of dialyser and blood lines.
    Preuschof L; Keller F; Seemann J; Offermann G
    Int J Artif Organs; 1988 Jul; 11(4):255-8. PubMed ID: 3410566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational approach to use of heparin during cardiac catheterization in children.
    Grady RM; Eisenberg PR; Bridges ND
    J Am Coll Cardiol; 1995 Mar; 25(3):725-9. PubMed ID: 7860920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
    Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
    Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodialysis without anticoagulation.
    Sanders PW; Taylor H; Curtis JJ
    Am J Kidney Dis; 1985 Jan; 5(1):32-5. PubMed ID: 3881017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
    Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
    Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circuit Lifetime With Citrate Versus Heparin in Pediatric Continuous Venovenous Hemodialysis.
    Zaoral T; Hladík M; Zapletalová J; Trávníček B; Gelnarová E
    Pediatr Crit Care Med; 2016 Sep; 17(9):e399-405. PubMed ID: 27427878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in the circulating heparin levels during maintenance hemodialysis in patients with end-stage renal disease.
    Kaneva K; Bansal V; Hoppensteadt D; Cunanan J; Fareed J
    Clin Appl Thromb Hemost; 2013; 19(4):449-52. PubMed ID: 23463188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid accelerated hemodialysis in children with end-stage renal disease: a randomized clinical trial.
    El Hatw MK; Fadel F; El Baroudy R
    Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):22-9. PubMed ID: 23354187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing hemorrhage in high-risk hemodialysis: regional versus low-dose heparin.
    Swartz RD; Port FK
    Kidney Int; 1979 Oct; 16(4):513-8. PubMed ID: 548596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of low-dose heparin in hemodialysis.
    Murea M; Russell GB; Daeihagh P; Saran AM; Pandya K; Cabrera M; Burkart JM; Freedman BI
    Hemodial Int; 2018 Jan; 22(1):74-81. PubMed ID: 28418614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of thrombelastography for dosage monitoring of low molecular weight heparin and unfractionated heparin during hemodialysis.
    Shinoda T; Arakura H; Katakura M; Shirota T; Nakagawa S
    Artif Organs; 1990 Dec; 14(6):413-5. PubMed ID: 2177970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.